C. Lass-florl et al., Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline, CLIN INF D, 33(12), 2001, pp. 135-136
Three patients with premenstrual dysphoric disorder (PMDD) and recurrent vu
lvovaginal candidiasis (VVC) underwent sertraline therapy (Tresleen, a sele
ctive serotonin-reuptake inhibitor; Pfizer) for PMDD. During sertraline int
ervention, patients had no recurrent episodes of acute VVC. Antifungal acti
vity was observed for sertraline against various isolates of Candida specie
s.